NO980252L - In vivo diabetes-test - Google Patents
In vivo diabetes-testInfo
- Publication number
- NO980252L NO980252L NO980252A NO980252A NO980252L NO 980252 L NO980252 L NO 980252L NO 980252 A NO980252 A NO 980252A NO 980252 A NO980252 A NO 980252A NO 980252 L NO980252 L NO 980252L
- Authority
- NO
- Norway
- Prior art keywords
- diabetes testing
- diagnosis
- vivo
- agent
- mediated diseases
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
Abstract
Oppfinnelsen angår anvendelsen av autoreaktive stoffer for fremstilling av et middel for diagnose av cellulært formidlede sykdommer eller en predisposisjon for cellulært formidlede sykdommer, hvor man appliserer midlet intradermalt og stiller diagnosen på basis av opptreden eller manglende opptreden av en positiv reaksjon på applikasjonsstedet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19526561A DE19526561A1 (de) | 1995-07-20 | 1995-07-20 | In-vivo-Diabetes-Test |
PCT/EP1996/003192 WO1997003704A2 (de) | 1995-07-20 | 1996-07-19 | In-vivo-diabetes-test |
Publications (2)
Publication Number | Publication Date |
---|---|
NO980252L true NO980252L (no) | 1998-01-20 |
NO980252D0 NO980252D0 (no) | 1998-01-20 |
Family
ID=7767366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO980252A NO980252D0 (no) | 1995-07-20 | 1998-01-20 | In vivo diabetes-test |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0839058A2 (no) |
JP (1) | JPH11509538A (no) |
KR (1) | KR19990035757A (no) |
CN (1) | CN1191493A (no) |
AU (1) | AU6658296A (no) |
CA (1) | CA2225145A1 (no) |
DE (1) | DE19526561A1 (no) |
IL (1) | IL122816A0 (no) |
NO (1) | NO980252D0 (no) |
WO (1) | WO1997003704A2 (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0923944A4 (en) * | 1996-04-01 | 2000-05-03 | Chugai Pharmaceutical Co Ltd | DIAGNOSTIC COMPOSITION FOR DISEASES ACCOMPANIED BY AUTO-IMMUNE REACTIONS TRIGGERED BY 65K-GLUTAMIC ACID DECARBOXYLASE |
US6750201B1 (en) | 1997-10-17 | 2004-06-15 | The Trustees Of The University Of Pennsylvania | Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
KR100681339B1 (ko) * | 2004-12-23 | 2007-02-15 | 최성환 | 연탄보일러 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3626054A (en) * | 1967-10-25 | 1971-12-07 | Bard Hamilton Co Inc | Lupus erythematosus skin test |
US5674978A (en) * | 1990-09-21 | 1997-10-07 | The Regents Of The University Of California | Peptides derived from glutamic acid decarboxylase |
CN1112933A (zh) * | 1994-01-20 | 1995-12-06 | 伯伦格·曼海姆有限公司 | 抗原特异性活化t淋巴细胞,其检测和用途 |
DE19525784A1 (de) * | 1995-07-14 | 1997-01-16 | Boehringer Mannheim Gmbh | Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD) |
-
1995
- 1995-07-20 DE DE19526561A patent/DE19526561A1/de not_active Withdrawn
-
1996
- 1996-07-19 IL IL12281696A patent/IL122816A0/xx unknown
- 1996-07-19 KR KR1019980700413A patent/KR19990035757A/ko not_active Application Discontinuation
- 1996-07-19 WO PCT/EP1996/003192 patent/WO1997003704A2/de not_active Application Discontinuation
- 1996-07-19 CA CA002225145A patent/CA2225145A1/en not_active Abandoned
- 1996-07-19 EP EP96926371A patent/EP0839058A2/de not_active Withdrawn
- 1996-07-19 JP JP9506304A patent/JPH11509538A/ja active Pending
- 1996-07-19 CN CN96195689A patent/CN1191493A/zh active Pending
- 1996-07-19 AU AU66582/96A patent/AU6658296A/en not_active Abandoned
-
1998
- 1998-01-20 NO NO980252A patent/NO980252D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL122816A0 (en) | 1998-08-16 |
WO1997003704A2 (de) | 1997-02-06 |
JPH11509538A (ja) | 1999-08-24 |
WO1997003704A3 (de) | 1997-06-05 |
AU6658296A (en) | 1997-02-18 |
CA2225145A1 (en) | 1997-02-06 |
KR19990035757A (ko) | 1999-05-25 |
CN1191493A (zh) | 1998-08-26 |
DE19526561A1 (de) | 1997-01-23 |
EP0839058A2 (de) | 1998-05-06 |
NO980252D0 (no) | 1998-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0301729A2 (hu) | Gyógyszer szívelégtelenség megelżzésére és kezelésére | |
ES2161669T1 (es) | Test de glucosa 13c por aliento para el diagnostico de indicaciones de diabetes y la monitorizacion del control glicemico. | |
HUP0101994A2 (hu) | Eszköz valamely gyógyszervegyület vérparaméterekre gyakorolt hatásainak in vivo meghatározására, valamint alkalmazása | |
PT1131039E (pt) | Utilizacao de uma substancia que se liga ao receptor periferico das benzodiazepinas no tratamento de stresses cutaneos | |
BR0103256A (pt) | Utilização de substâncias bioquìmicas para uma composição para a prevenção e tratamento de condições de saúde causadas por constrição de células de músculo liso em órgãos do corpo humano | |
ES2189961T3 (es) | Un ensayo de diagnostico para la esquizofrenia que emplea niacina. | |
NO980252L (no) | In vivo diabetes-test | |
DK0795130T3 (da) | Diagnostisk metode ved inflammatoriske tilstande i tarmene | |
ATE213082T1 (de) | Notruf- oder diagnosegerät | |
Cairns et al. | Computerized version of the time-insensitive predictive instrument. Use of the Q wave, ST-segment, T wave, and patient history in the diagnosis of acute myocardial infarction by the computerized ECG | |
DE69839314D1 (de) | Diagnosemittel für Diabetes, das 13C-markierte Zusammensetzung enthält | |
DK0568554T3 (da) | Fremgangsmåde til påvisning af anti-RNA-antistoffer | |
MD121B1 (ro) | Procedeu de obtinere a derivatilor tienopiranului | |
ATE320272T1 (de) | Verwendung von kontrastmitteln zur herstellung eines diagnostischen mittels für die darm- lumenbildgebung | |
DE69623325D1 (de) | 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus | |
Rosati et al. | Clinical validity of the elbow flexion test for the diagnosis of ulnar nerve compression at the cubital tunnel | |
DE69405284D1 (de) | Manschette für Blutdruckmesser | |
DK0789591T3 (da) | Fremgangsmåde til identifikation af individer, som lider af en celleabnormitet | |
Wide | Mercury hazards arising from the repair of sphygmomanometers. | |
Litt | Ephebiatric Lingo | |
PT1108211E (pt) | Metodo para testar a toxicidade de substancias quimicas usando gastropodes | |
KR970020057A (ko) | 혈압계 시계 | |
DK0610196T3 (da) | Fremgangsmåde til diagnose af ikke-insulinafhængig diabetes mellitus | |
Notowicz et al. | Solitary Papular Lesions on the Penis in Insufficiently Treated early Syphilis: A Report of Two Cases | |
UA34311A (uk) | Спосіб оцінки клінічного стану хворого |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |